Request a consultation

Lightbox 3Lightbox 2

There’s new hope for cancer patients and their families thanks to the Ochsner Precision Cancer Therapies Program. It’s the region’s only program dedicated to bringing early phase clinical trials to the Gulf South. That means you can get access to advanced, groundbreaking cancer treatments early.


Hidden text for Hind Bold

Leading the Way in Cancer Care

The Gayle and Tom Benson Cancer Center has been awarded

three-year accreditation

from the Commission on Cancer of the American College of Surgeons.

Ochsner is ranked No. 1 in the New Orleans metro area and recognized among the Best Hospitals in southeastern Louisiana by U.S. News & World Report.

Ochsner cancer specialists reviewing patient information on a laptop

Innovative Cancer Clinical Trials, Close to Home

Cancer Clinical Trials, Near You

Ochsner cancer specialists reviewing patient information on a laptop


Cancer Clinical Trials

Ochsner conducts more than 130 cancer clinical trials every year.

A Day in the Life of the Cancer Experts at Ochsner

Groundbreaking Clinical Trials for Cancer Patients

Our Location

Gayle and Tom Benson Cancer Center
1514 Jefferson Hwy.
New Orleans, LA 70121
Schedule Online

Leading the Way in Cancer Care

Cancer Clinical Trials, Near You

The Ochsner Precision Cancer Therapies team provides the most advanced cancer care available and offers compassionate support to patients and their families.

Our Team

Our Team

The Leaders in Clinical Trials

We’re home to the largest clinical trials network in Louisiana, including early phase trials and a powerful partnership with TGen, a leading research institute. Plus, we're expanding our office space this year to give us even more room to serve our patients.

Access to Innovative Treatments

We offer clinical trials that aren’t available elsewhere. Plus, we offer the latest in treatment, research and advanced testing, so you won’t have to travel far to get the best cancer care possible.

Coordinated Care

An experienced and fully dedicated team of doctors, nurses, researchers and more works hand-in-hand with your physician, ensuring you receive comprehensive, collaborative care.

Personalized Treatment

As a patient, you’ll benefit from a customized care plan that is based on the most up-to-date research and your cancer’s unique genetic profile.

What Is a Clinical Trial and How Can It Help Me?

Learn how our cutting-edge research can translate into lifesaving care for you.

Advanced Care

Patients have access to additional services including free next generation sequencing; nutrition, psychological and palliative care support; and chemo care companion for high-risk monitoring at home.

Marc Matrana

Marc Matrana, MD, MS, FACP
Medical Director, Ochsner Precision Cancer Therapies Program

As the leader of the Ochsner Precision Cancer Therapies Program, Dr. Matrana focuses on treating patients with cancers of the genitourinary tract, lung cancer, gastrointestinal cancer, and other solid tumors. He is a native of New Orleans, who trained at MD Anderson Cancer Center in Houston where he served as Chief Fellow. His groundbreaking research has led to numerous peer-reviewed articles, chapters and other publications in the field of genitourinary medical oncology. In addition to research and patient care, Dr. Matrana is an active medical educator who has spoken to groups around the world.

Daniel Von Hoff

Daniel Von Hoff, MD, FACP
Senior Consultant

Dr. Von Hoff is currently Physician-in-Chief and Distinguished Professor at TGen (Translational Genomics Research Institute) in Phoenix, Arizona. Dr. Von Hoff’s major interest is in the development of anticancer agents. He is a winner of the prestigious Karnofsky award for outstanding achievements in cancer research and impact on treatment of cancer patients.

Daniel Johnson

Daniel Johnson, MD
Deputy Medical Director, Ochsner Precision Cancer Therapies Program

Dr. Johnson, medical oncologist, specializes in treating melanoma patients and has special research interests in strategies to overcome immunotherapy resistance and prevent immune related adverse events. He has multiple peer-reviewed articles and presentations at national meetings pertaining to the management and underlying mechanisms of immune toxicity. Dr. Johnson is a clinical investigator focused on designing and implementing clinical trials intended to optimize the safety and efficacy of immune checkpoint inhibitors.

Laura Finn

Laura Finn, MD
Deputy Medical Director, Hematology, Precision Cancer Therapies Program

Dr. Finn is the Interim Director of Ochsner’s Hematology and Bone Marrow Transplant Program. She completed a Hematology/Oncology fellowship at the Mayo Clinic in Jacksonville, FL where she was chief fellow and remained on faculty for two years as an Assistant Professor of Medicine. She completed advanced training in Bone Marrow Transplant at the University of Minnesota. She is the author of numerous peer reviewed publications in Hematology, Bone Marrow Transplant and use of Palliative Medicine in cancer care and speaks globally on these topics. As a clinical investigator, Dr. Finn is focused on therapeutic trials for the treatment of hematologic malignancies and enhancement of bone marrow transplant.

Katrina Wade

Katrina Wade, MD
Key Investigator

Dr. Katrina Wade’s area of clinical expertise is gynecologic cancers, including cervical, uterine, vulvar and ovarian cancer, as well as gestational trophoblastic disease. She is board certified in Gynecologic Oncology and has been recognized for her research in the field of gynecologic oncology. She is widely published in peer-reviewed medical journals and serves on the Ovarian Cancer committee for NRG oncology. Dr. Wade strongly believes in a multidisciplinary team approach to gynecologic cancer care. She seeks to provide women with the most advanced and personalized treatment plans while best preserving quality of life.

Erin Pierce

Erin Pierce, MSN, APRN, FNP-C
Key Investigator

Erin Pierce received a Master of Science in Nursing from the University of South Alabama and a Bachelor of Science in Nursing from Louisiana State University. She serves as a sub-investigator on clinical trials and collaborates with physicians to care for patients enrolled in the Precision Cancer Therapies Program. Her special areas of interest are genitourinary and early phase clinical trials. She was chosen as the 2018 Ochsner Advanced Practice Provider of the Year for her research contributions.

John Cole

John Cole, MD
Medical Director of Oncology Research

Completed his Hematology /Oncology Fellowship at Columbia Presbyterian Medical Center in New York. He joined the Ochsner faculty in 1989. He has been Principal Investigator of the Ochsner NCORP since 2017 and is currently the Director of Clinical Cancer Research for Ochsner Health System. His major personal research focus is on Breast Cancer clinical trials.

Brian A. Moore

Brian A. Moore, MD, FACS
Medical Director, Ochsner Cancer Institute

Dr. Moore is OHS Cancer Center Director and Chairman of the ENT Department. After a residency in Otolaryngology-Head and Neck surgery at Vanderbilt, he completed a fellowship at MD Anderson Cancer Center in Head and Neck Surgical Oncology and Reconstruction. He has published numerous papers and book chapters related to surgical reconstruction and head and neck cancers. His clinical interests include advanced skin cancer/melanoma, salivary gland disorders and thyroid/parathyroid disorders.